A05 Cellular and regional gene expression changes in human Huntington's disease cortex correlate with symptom profiles

Thu, D; Oorschot, D; Tippett, L; Hogg, V; Waldvogel, H; Faull, R; Luthi-Carter, R
September 2010
Journal of Neurology, Neurosurgery & Psychiatry;Sep2010 Supp, Vol. 81, pA2
Academic Journal
Background Huntington's disease (HD) presents with variable symptomatologies, including motor and mood changes. The regional, cellular and molecular underpinnings of symptom heterogeneity remain largely unknown, particularly in the cerebral cortex. Aims This study addressed the hypotheses that varying symptomatologies of HD correlate with differential cortical cell loss and gene expression across cortical subregions. Methods A double blind study of 12 HD and 15 control brains determined the extent of cell loss in four regions of the cerebral cortex comprising the motor (primary motor cortex), premotor (superior frontal gyrus), somatosensory (primary sensory cortex) and limbic (anterior cingulate gyrus) cortices. The HD cases were categorised into three groups according to their main early symptomatologies (motor, mood or mixed (motor/mood)). In parallel, we examined differential gene expression in the pyramidal neurons in layer V in a subset of the same brains comprising six control and eight HD cases (four with motor symptoms and four with mood symptoms) implementing laser capture microdissection combined with microarray analysis. Results Stereological analyses revealed marked heterogeneous neuronal loss across cortical subregions that showed region specific correlations to particular HD symptomatologies. Specifically, motor symptom cases showed a greater cell loss in the motor, premotor and somatosensory cortices whereas mood symptoms showed greater loss in the limbic cortex, and mixed symptom cases showed cell loss in multiple cortical subfields. Gene expression changes also showed a symptom correlated distribution, with more changes in the primary motor cortex in motor cases and more changes in the anterior cingulate cortex in mood cases. Conclusions These findings provide new quantitative evidence that the heterogeneity in the pattern of cell loss and gene expression in the cerebral cortex of the HD brain underlies variable clinical symptomatology. Ongoing studies will assess whether specific genes or molecular pathways can be implicated in these differential HD related effects.


Related Articles

  • Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease. Novak, Marianne J. U.; Warren, Jason D.; Henley, Susie M. D.; Draganski, Bogdan; Frackowiak, Richard S.; Tabrizi, Sarah J. // Brain: A Journal of Neurology;Apr2012, Vol. 135 Issue 4, p1165 

    Huntington's disease is an inherited neurodegenerative disease that causes motor, cognitive and psychiatric impairment, including an early decline in ability to recognize emotional states in others. The pathophysiology underlying the earliest manifestations of the disease is not fully...

  • Lipid Pathway Alterations in Parkinson's Disease Primary Visual Cortex. Cheng, Danni; Jenner, Andrew M.; Shui, Guanghou; Cheong, Wei Fun; Mitchell, Todd W.; Nealon, Jessica R.; Kim, Woojin S.; McCann, Heather; Wenk, Markus R.; Halliday, Glenda M.; Garner, Brett // PLoS ONE;2011, Vol. 6 Issue 2, p1 

    Background: We present a lipidomics analysis of human Parkinson's disease tissues. We have focused on the primary visual cortex, a region that is devoid of pathological changes and Lewy bodies; and two additional regions, the amygdala and anterior cingulate cortex which contain Lewy bodies at...

  • Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease. McColgan, Peter; Seunarine, Kiran K.; Razi, Adeel; Cole, James H.; Gregory, Sarah; Durr, Alexandra; Roos, Raymund A. C.; Stout, Julie C.; Landwehrmeyer, Bernhard; Scahill, Rachael I.; Clark, Chris A.; Rees, Geraint; Tabrizi, Sarah J.; Track-HD Investigators // Brain: A Journal of Neurology;Nov2015, Vol. 138 Issue 11, p3327 

    Huntington's disease can be predicted many years before symptom onset, and thus makes an ideal model for studying the earliest mechanisms of neurodegeneration. Diffuse patterns of structural connectivity loss occur in the basal ganglia and cortex early in the disease. However, the organizational...

  • Post-mortem molecular profiling of three psychiatric disorders. Ramaker, Ryne C.; Bowling, Kevin M.; Lasseigne, Brittany N.; Hagenauer, Megan H.; Hardigan, Andrew A.; Davis, Nicholas S.; Gertz, Jason; Cartagena, Preston M.; Walsh, David M.; Vawter, Marquis P.; Jones, Edward G.; Schatzberg, Alan F.; Barchas, Jack D.; Watson, Stanley J.; Bunney, Blynn G.; Akil, Huda; Bunney, William E.; Li, Jun Z.; Cooper, Sara J.; Myers, Richard M. // Genome Medicine;7/28/2017, Vol. 9, p1 

    Background: Psychiatric disorders are multigenic diseases with complex etiology that contribute significantly to human morbidity and mortality. Although clinically distinct, several disorders share many symptoms, suggesting common underlying molecular changes exist that may implicate important...

  • H05 Gene expression profile in fibroblasts of Huntington's disease patients and controls. Marchina, E; Bozzato, A; Ferraboli, S; Agosti, C; Rozzini, L; Borsani, G; Barlati, S; Padovani, A // Journal of Neurology, Neurosurgery & Psychiatry;Sep2010 Supp, Vol. 81, pA35 

    Huntington's disease (HD), MIM 143100, is a dominantly inherited progressive neurodegenerative disorder characterised by motor, behavioural and cognitive dysfunction, caused by an expanded CAG repeat region in exon 1 of the HTT gene. This mutation results in the presence of an abnormally long...

  • Tracking the Origin of Huntington's Disease in the Brain.  // Bioscience Technology;Apr2014, p1 

    The article discusses the study on the origin of Huntington's disease in the brain, a disease passed from parent to child through mutation of huntingtin gene, that targets cells in cortex and striatum regions of the brain. It discusses integration of a genetic scissors to snip off stutter and...

  • Conservation of Regional Gene Expression in Mouse and Human Brain. Strand, Andrew D.; Aragaki, Aaron K.; Baquet, Zachary C.; Hodges, Angela; Cunningham, Philip; Holmans, Peter; Jones, Kevin R.; Jones, Lesley; Kooperberg, Charles; Olson, James M. // PLoS Genetics;Apr2007, Vol. 3 Issue 4, pe59 

    Many neurodegenerative diseases have a hallmark regional and cellular pathology. Gene expression analysis of healthy tissues may provide clues to the differences that distinguish resistant and sensitive tissues and cell types. Comparative analysis of gene expression in healthy mouse and human...

  • Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease. Niccolini, Flavia; Haider, Salman; Marques, Tiago Reis; Muhlert, Nils; Tziortzi, Andri C.; Searle, Graham E.; Natesan, Sridhar; Piccini, Paola; Kapur, Shitij; Rabiner, Eugenii A.; Gunn, Roger N.; Tabrizi, Sarah J.; Politis, Marios; Reis Marques, Tiago // Brain: A Journal of Neurology;10/1/2015, Vol. 138 Issue 10, p3016 

    There is an urgent need for early biomarkers and novel disease-modifying therapies in Huntington's disease. Huntington's disease pathology involves the toxic effect of mutant huntingtin primarily in striatal medium spiny neurons, which highly express phosphodiesterase 10A (PDE10A). PDE10A...

  • A common gene expression signature in Huntington's disease patient brain regions. Neueder, Andreas; Bates, Gillian P. // BMC Medical Genomics;2014, Vol. 7 Issue 1, p1 

    Background Gene expression data provide invaluable insights into disease mechanisms. In Huntington's disease (HD), a neurodegenerative disease caused by a tri-nucleotide repeat expansion in the huntingtin gene, extensive transcriptional dysregulation has been reported. Conventional dysregulation...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics